Study of Procoagulation Markers in Stroke Patients

CompletedOBSERVATIONAL
Enrollment

271

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

October 31, 2018

Study Completion Date

January 31, 2019

Conditions
StrokeHyperglycemiaProcoagulation Markers
Interventions
OTHER

Glycemic Control

Trial Locations (38)

10029

Mount Sinai Medical Center, New York

10032

Columbia University Medical Center, New York

10451

Lincoln Medical and Mental Health Center, New York

11203

Kings County Hospital, Brooklyn

SUNY Downstate University Hospital of Brooklyn, Brooklyn

14210

Kaleida Stroke Center, SUNY Buffalo, Buffalo

15219

UPMC - Mercy, Pittsburgh

15261

UPMC - Presbyterian, Pittsburgh

19001

Abington Memorial Hospital, Abington

19104

Hospital of the University of Pennsylvania, Philadelphia

19140

Temple University Hospital, Philadelphia

20010

Medstar Washington Hospital Center, Washington D.C.

22908

University of Virginia, Charlottesville

26506

West Virginia University, Morgantown

30322

Emory University Hospital, Atlanta

Grady Memorial Hospital, Atlanta

30912

Augusta University, Augusta

32224

Mayo Clinic Jacksonville, Jacksonville

40506

University of Kentucky, Lexington

43210

Wexner Medical Center, Columbus

44304

Summa Health System, Akron

45221

University of Cincinnati, Cincinnati

48201

Detroit Receiving Hospital, Detroit

48235

Sinai-Grace Hospital, Detroit

52242

University of Iowa Hospitals & Clinics, Iowa City

53226

Froedtert Memorial Lutheran Hospital, Milwaukee

55415

Hennepin County Medical Center, Minneapolis

55455

University of Minnesota Medical Center, Fairview, Minneapolis

75390

UT Southwestern-Parkland Memorial Hospital, Dallas

UT Southwestern-Zale Lipshy University Hospital, Dallas

77030

Memorial Hermann Hospital, Houston

84132

University of Utah, Salt Lake City

85724

Banner University Medical Center, Tucson

90095

Ronald Regan Medical Center, Los Angeles

90806

Long Beach Memorial Hospital, Long Beach

94110

San Francisco General Hospital, San Francisco

94305

Stanford University Medical Center, Stanford

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

collaborator

Neurological Emergencies Treatment Trials Network (NETT)

NETWORK

collaborator

University of Virginia

OTHER

collaborator

University of Michigan

OTHER

collaborator

Medical University of South Carolina

OTHER

collaborator

Augusta University

OTHER

lead

Temple University

OTHER

NCT01811550 - Study of Procoagulation Markers in Stroke Patients | Biotech Hunter | Biotech Hunter